• Login
    View Item 
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Author
    Bright, B.
    Babalola, C.P.
    Sam-Agudu, N.A.
    Onyeaghala, A.A.
    Olatunji, A.
    Aduh, U.
    Sobande, P.O.
    Crowell, T.A.
    Tebeje, Y.K.
    Phillip, S.
    Ndembi, N.
    Folayan, M.O.
    Show allShow less

    Date
    2021-03-03
    Journal
    Globalization and Health
    Publisher
    Springer Nature
    Type
    Article
    
    Metadata
    Show full item record
    See at
    https://doi.org/10.1186/s12992-021-00668-6
    Abstract
    Objective: The COVID-19 pandemic is a biosecurity threat, and many resource-rich countries are stockpiling and/or making plans to secure supplies of vaccine, therapeutics, and diagnostics for their citizens. We review the products that are being investigated for the prevention, diagnosis, and treatment of COVID-19; discuss the challenges that countries in sub-Saharan Africa may face with access to COVID-19 vaccine, therapeutics, and diagnostics due to the limited capacity to manufacture them in Africa; and make recommendations on actions to mitigate these challenges and ensure health security in sub-Saharan Africa during this unprecedented pandemic and future public-health crises. Main body: Sub-Saharan Africa will not be self-reliant for COVID-19 vaccines when they are developed. It can, however, take advantage of existing initiatives aimed at supporting COVID-19 vaccine access to resource-limited settings such as partnership with AstraZeneca, the Coalition for Epidemic Preparedness and Innovation, the Global Alliance for Vaccine and Immunisation, the Serum Institute of India, and the World Health Organization's COVID-19 Technology Access Pool. Accessing effective COVID-19 therapeutics will also be a major challenge for countries in sub-Saharan Africa, as production of therapeutics is frequently geared towards profitable Western markets and is ill-adapted to sub-Saharan Africa realities. The region can benefit from pooled procurement of COVID-19 therapy by the Africa Centres for Disease Control and Prevention in partnership with the African Union. If the use of convalescent plasma for the treatment of patients who are severely ill is found to be effective, access to the product will be minimally challenging since the region has a pool of recovered patients and human resources that can man supportive laboratories. The region also needs to drive the local development of rapid-test kits and other diagnostics for COVID-19. Conclusion: Access to vaccines, therapeutics, and diagnostics for COVID-19 will be a challenge for sub-Saharan Africans. This challenge should be confronted by collaborating with vaccine developers; pooled procurement of COVID-19 therapeutics; and local development of testing and diagnostic materials. The COVID-19 pandemic should be a wake-up call for sub-Saharan Africa to build vaccines, therapeutics, and diagnostics manufacturing capacity as one of the resources needed to address public-health crises. Copyright 2021, The Author(s).
    Keyword
    COVID-19
    Diagnostics
    Manufacturing capability
    Sub-Saharan Africa
    Therapeutics
    Vaccine
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/15178
    ae974a485f413a2113503eed53cd6c53
    10.1186/s12992-021-00668-6
    Scopus Count
    Collections
    UMB Open Access Articles
    UMB Coronavirus Publications

    entitlement

    Related articles

    • A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness.
    • Authors: Amin T, Kesselheim AS
    • Issue date: 2022 Jan-Dec
    • Things must not fall apart: the ripple effects of the COVID-19 pandemic on children in sub-Saharan Africa.
    • Authors: Coker M, Folayan MO, Michelow IC, Oladokun RE, Torbunde N, Sam-Agudu NA
    • Issue date: 2021 Apr
    • Limited handwashing facility and associated factors in sub-Saharan Africa: pooled prevalence and multilevel analysis of 29 sub-Saharan Africa countries from demographic health survey data.
    • Authors: Endalew M, Belay DG, Tsega NT, Aragaw FM, Gashaw M, Asratie MH
    • Issue date: 2022 Oct 27
    • Equal access of COVID-19 vaccine distribution in Africa: Challenges and way forward.
    • Authors: Aborode AT, Olofinsao OA, Osmond E, Batubo AP, Fayemiro O, Sherifdeen O, Muraina L, Obadawo BS, Ahmad S, Fajemisin EA
    • Issue date: 2021 Sep
    • Digital health and COVID-19: challenges of use and implementation in sub-Saharan Africa.
    • Authors: Mogessie YG, Ntacyabukura B, Mengesha DT, Musa MB, Wangari MC, Claude N, Buntongyi N, Lucero-Prisno DE
    • Issue date: 2021
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.